ロード中...
Imatinib improves insulin resistance and inhibits injury-induced neointimal hyperplasia in high fat diet-fed mice
Imatinib, a PDGF receptor tyrosine kinase inhibitor, has been shown to suppress intimal hyperplasia in different animal models under normal metabolic milieu, diabetic, and/or hypercholesterolemic conditions. However, the impact of imatinib treatment on injury-induced neointimal hyperplasia has not y...
保存先:
| 出版年: | Eur J Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7749815/ https://ncbi.nlm.nih.gov/pubmed/33131722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173666 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|